Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Multicenter, Randomized, Double-Blind, Active Comparator Controlled Study of the Immunogenicity and Safety of VAX2012Q, A Quadrivalent Influenza Vaccine in Healthy Adults 18-64 Years

NCT02434276 is registered in ClinicalTrials.gov with VaxInnate Corporation as lead sponsor.

NCT NCT02434276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02434276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Multicenter, Randomized, Double-Blind, Active Comparator Controlled Study of the Immunogenicity and Safety of VAX2012Q, A Quadrivalent Influenza Vaccine in Healthy Adults 18-64 Years
Lead sponsor
VaxInnate Corporation
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2015
Completion date
June 30, 2016
Enrollment
450 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

influenza